Incidence of HCV Induced-Esophageal Varices in Egypt: Valuable Knowledge Using Data Mining Analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2017 Jan 26

PMID 28121921

Citations 3

Authors

Mahmoud Abdel-Aty

Mahmoud Fouad

Mohammad M Sallam

Elsayed A Elgohary

Ali Ismael

Abdallah Nawara

Baha Hawary

Mohammed Tag-Adeen

Salama Khaled

Affiliations

Soon will be listed here.

Abstract

Esophageal varices is one of the most important comorbidity related liver cirrhosis, patients usually presented with hematemesis, melena, or both, ultimately 20% is the mortality during the first attack, hence we aimed to investigate the incidence of such esophageal varices related chronic Hepatitis C virus (HCV) in randomized Egyptian population.One thousand eighteen Egyptian patients, aged between 17 and 58 years, positive for Hepatitis C virus genotype 4 (HCV-4) by enzyme linked immunosorbent assay Ab and HCV RNA-polymerase chain reaction were screened for the presence of esophageal varices.Incidence of esophageal varices was 62.3%; 635 patients, those with large Esophageal varices (LEVs) was 47.4%; 301 patients. Model for end-stage liver disease (MELD) score has not been significantly improved post variceal band ligation (VBL). Using 2D U/S was useful for EVs prediction.Incidence of esophageal varices in HCV Egyptian patients still high, valuable knowledge would be helpful in clinical field have been discovered by data mining computational intelligent analysis using in practical medicine to improve overall health care.

Citing Articles

EUS-guided cyanoacrylate injection into the perforating vein versus direct endoscopic injection in the treatment of gastric varices.

Sabry F, Seif S, Eldesoky A, Hakim H, Altonbary A Endosc Int Open. 2023; 11(2):E202-E210.

PMID: 36845270 PMC: 9949986. DOI: 10.1055/a-1984-7070.

Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C.

Ahmed H, Waly N, Abd El-Baky R, Yahia R, Hetta H, Elsayed A PLoS One. 2021; 16(4):e0249770.

PMID: 33857212 PMC: 8049381. DOI: 10.1371/journal.pone.0249770.

Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis.

Abdel-Aziz A, Ibrahim M, El-Sheikh A, Kamel M, Zenhom N, Abdel-Raheim S J Clin Exp Hepatol. 2018; 8(1):15-22.

PMID: 29743792 PMC: 5938328. DOI: 10.1016/j.jceh.2017.06.006.

References

Stoszek S, Abdel-Hamid M, Narooz S, Daly M, Saleh D, Mikhail N . Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Trans R Soc Trop Med Hyg. 2005; 100(2):102-7. DOI: 10.1016/j.trstmh.2005.05.021. View

Floreani A . Hepatitis C and pregnancy. World J Gastroenterol. 2013; 19(40):6714-20. PMC: 3812470. DOI: 10.3748/wjg.v19.i40.6714. View

Abd Elrazek M, Mohammad Ali A, Mahfouz H, Afifi M, Nafady M, Fathy A . Detection of risky esophageal varices by two-dimensional ultrasound: when to perform endoscopy. Am J Med Sci. 2012; 347(1):28-33. DOI: 10.1097/MAJ.0b013e3182750ce8. View

Hayashida A, Inaba N, Oshima K, Nishikawa M, Shoda A, Hayashida S . Re-evaluation of the true rate of hepatitis C virus mother-to-child transmission and its novel risk factors based on our two prospective studies. J Obstet Gynaecol Res. 2007; 33(4):417-22. DOI: 10.1111/j.1447-0756.2007.00582.x. View

Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S . Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006; 55(8):1183-7. PMC: 1856273. DOI: 10.1136/gut.2005.078147. View

El-Zayadi A, Badran H, Barakat E, Attia M, Shawky S, Mohamed M . Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol. 2005; 11(33):5193-8. PMC: 4320394. DOI: 10.3748/wjg.v11.i33.5193. View

Lu S, Jin B, Cowart L, Lu X . From data towards knowledge: revealing the architecture of signaling systems by unifying knowledge mining and data mining of systematic perturbation data. PLoS One. 2013; 8(4):e61134. PMC: 3634064. DOI: 10.1371/journal.pone.0061134. View

Amitrano L, Guardascione M, Bennato R, Manguso F, Balzano A . MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol. 2005; 42(6):820-5. DOI: 10.1016/j.jhep.2005.01.021. View

Hajarizadeh B, Grebely J, Dore G . Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013; 10(9):553-62. DOI: 10.1038/nrgastro.2013.107. View

10.

Abd Elrazek A, Mahfouz H, Metwally A, El-Shamy A . Mortality prediction of nonalcoholic patients presenting with upper gastrointestinal bleeding using data mining. Eur J Gastroenterol Hepatol. 2013; 26(2):187-91. DOI: 10.1097/MEG.0b013e328365c3b0. View

11.

Fukuhara T, Taketomi A, Okano S, Ikegami T, Soejima Y, Shirabe K . Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation. J Hepatol. 2010; 52(5):672-80. DOI: 10.1016/j.jhep.2009.10.034. View

12.

Tovo P, Palomba E, Ferraris G, Principi N, Ruga E, Dallacasa P . Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis. 1997; 25(5):1121-4. DOI: 10.1086/516102. View

13.

Abd Elrazek A, Mahfouz H, Elazeem K, Fakhry M, Elrazek E, Foad M . The Value of U/S to Determine Priority for Upper Gastrointestinal Endoscopy in Emergency Room. Medicine (Baltimore). 2015; 94(49):e2241. PMC: 5008513. DOI: 10.1097/MD.0000000000002241. View

14.

Abd Elrazek A, Bilasy S, Elbanna A, Elsherif A . Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis. Medicine (Baltimore). 2014; 93(28):e204. PMC: 4603091. DOI: 10.1097/MD.0000000000000204. View

15.

Elrazek A, Amer M, El-Hawary B, Salah A, Bhagavathula A, Alboraie M . Prediction of HCV vertical transmission: what factors should be optimized using data mining computational analysis. Liver Int. 2016; 37(4):529-533. DOI: 10.1111/liv.13146. View

16.

Annunziata T, Paulino K, Fernandes R, Bento G, Stoduto G, Vasconcelos R . Impact of Model for End-stage Liver Disease Score in Post-Liver Transplantation Prognosis. Transplant Proc. 2016; 48(7):2348-2351. DOI: 10.1016/j.transproceed.2016.08.003. View

17.

Guo X, Yang G, Yuan J, Ruan P, Zhang M, Chen X . Genetic variation in interleukin 28B and response to antiviral therapy in patients with dual chronic infection with hepatitis B and C viruses. PLoS One. 2013; 8(10):e77911. PMC: 3798462. DOI: 10.1371/journal.pone.0077911. View

18.

Mast E, Hwang L, Seto D, Nolte F, Nainan O, Wurtzel H . Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005; 192(11):1880-9. DOI: 10.1086/497701. View

19.

Roberts E, Yeung L . Maternal-infant transmission of hepatitis C virus infection. Hepatology. 2002; 36(5 Suppl 1):S106-13. DOI: 10.1053/jhep.2002.36792. View

20.

Mohd Hanafiah K, Groeger J, Flaxman A, Wiersma S . Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2012; 57(4):1333-42. DOI: 10.1002/hep.26141. View